DIAMOND AF Post-Approval Study (DAF PAS)
Sponsor: Medtronic Cardiac Ablation Solutions
Terminated
Sponsor and FDA agreed on early termination.
Other terminated trials from Medtronic Cardiac Ablation Solutions
See all terminations from Medtronic Cardiac Ablation Solutions
This observational or N/A phase trial investigates Paroxysmal Atrial Fibrillation and is currently terminated or withdrawn. Medtronic Cardiac Ablation Solutions leads this study, which shows 17 recorded versions since 2022 — indicating substantial longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
17 versions recorded-
Feb 2026 — Present [monthly]
Terminated
Status: Active Not Recruiting → Terminated
-
Dec 2025 — Feb 2026 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Sep 2025 — Dec 2025 [monthly]
Recruiting
-
May 2025 — Sep 2025 [monthly]
Recruiting
-
Mar 2025 — May 2025 [monthly]
Recruiting
▶ Show 12 earlier versions
-
Jan 2025 — Mar 2025 [monthly]
Recruiting
-
Sep 2024 — Jan 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
May 2024 — Jul 2024 [monthly]
Recruiting
-
Feb 2024 — May 2024 [monthly]
Recruiting
-
Nov 2023 — Feb 2024 [monthly]
Recruiting
-
Aug 2023 — Nov 2023 [monthly]
Recruiting
-
May 2023 — Aug 2023 [monthly]
Recruiting
-
Feb 2023 — May 2023 [monthly]
Recruiting
-
Sep 2022 — Feb 2023 [monthly]
Recruiting
-
Apr 2022 — Sep 2022 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Mar 2022 — Apr 2022 [monthly]
Not Yet Recruiting
First recorded
Feb 2022
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Medtronic Cardiac Ablation Solutions
For direct contact, visit the study record on ClinicalTrials.gov .